Affinage

ZNF280C

Zinc finger protein 280C · UniProt Q8ND82

Length
737 aa
Mass
83.1 kDa
Annotated
2026-06-11
6 papers in source corpus 3 papers cited in narrative 4 extracted findings
Cross-family judge faithfulness: 3/3 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

ZNF280C (ZPET) is a C2H2 zinc finger protein operating at the interface of the DNA damage response and chromatin-based gene repression (PMID:30567999, PMID:35605119). As a single-stranded DNA-binding protein, it localizes to double-strand breaks and stalled replication forks, where it blocks MRE11 association with ssDNA to slow DNA end resection independently of 53BP1 and HELB, thereby acting as a repressor of homologous recombination; its loss elevates HR, accelerates forks under replication stress, and confers resistance to DSB-inducing agents and PARP inhibition (PMID:30567999). In a parallel chromatin role, ZNF280C occupies H3K27me3-marked loci, co-localizes with and counteracts CTCF/cohesin to condense chromatin at tumor suppressor cis-elements, and recruits SMCHD1 to sustain focal and broad H3K27me3, promoting colorectal tumorigenesis (PMID:35605119). Beyond these two arms, no unifying mechanism connecting its resection-control and transcriptional-repression activities has been characterized in the available corpus.

Mechanistic history

Synthesis pass · year-by-year structured walk · 4 steps
  1. 2018 High

    Established ZNF280C as a direct biochemical regulator of DNA end resection, answering how an ssDNA-binding factor restrains the nuclease step of repair.

    Evidence BioID proximity proteomics, in vitro ssDNA-binding and MRE11-inhibition assays, chromatin fractionation in depleted cells

    PMID:30567999

    Open questions at the time
    • Does not define how ZPET is recruited to or removed from breaks
    • Structural basis of ssDNA binding and MRE11 competition unresolved
  2. 2018 High

    Defined the cellular consequence of ZNF280C activity by showing its loss enhances HR and alters fork dynamics, framing it as an HR repressor with therapeutic relevance to PARP inhibition.

    Evidence Loss-of-function with HR assay, DNA fiber assay, clonogenic survival after DSB agents and PARPi

    PMID:30567999

    Open questions at the time
    • Does not address pathway choice regulation at the chromatin level
    • Relationship to other resection antagonists not delineated
  3. 2022 High

    Revealed a distinct transcriptional/epigenetic function, showing ZNF280C maintains H3K27me3-dependent silencing by opposing CTCF/cohesin and recruiting SMCHD1 at tumor suppressor loci.

    Evidence ChIP-seq, ATAC-seq, CRISPRi/RNAi with H3K27me3 quantification, Co-IP, xenograft and colorectal tumorigenesis models

    PMID:35605119

    Open questions at the time
    • Mechanism linking DNA-binding to chromatin condensation unclear
    • Whether DSB and chromatin-repression roles are coupled is unknown
  4. 2026 Medium

    Identified a new physical partner (KMT5C) and a non-canonical chromatin context, raising the possibility that ZNF280C directs H4K20me3 deposition outside classical heterochromatin.

    Evidence Co-IP/pulldown and ChIP-seq co-localization at H3K9me3-/H4K20me3+ sites (preprint)

    PMID:42182233

    Open questions at the time
    • Single preprint, not peer-reviewed
    • Functional consequence of KMT5C recruitment not tested
    • Reciprocal interaction validation lacking

Open questions

Synthesis pass · forward-looking unresolved questions
  • Whether the resection-control and chromatin-repression functions of ZNF280C reflect one integrated mechanism or two separable activities remains unresolved.
  • No structural model of ZNF280C
  • No unifying model connecting DSB and transcriptional roles
  • Domain requirements for each function undefined

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0003677 DNA binding 2 GO:0098772 molecular function regulator activity 1 GO:0140110 transcription regulator activity 1
Localization
GO:0005634 nucleus 2 GO:0000228 nuclear chromosome 1
Pathway
R-HSA-73894 DNA Repair 2 R-HSA-4839726 Chromatin organization 1 R-HSA-69306 DNA Replication 1

Evidence

Reading pass · 4 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2018 ZPET/ZNF280C binds single-stranded DNA (ssDNA) and localizes to DNA double-strand breaks (DSBs) and stalled replication forks, where it inhibits MRE11 binding to ssDNA in vitro and delays MRE11 chromatin association after DSB formation in cells, thereby slowing DNA end resection independently of 53BP1 and HELB. Localized protein biotinylation (BioID with RAD18-BirAR118G fusion), in vitro ssDNA-binding assay, in vitro MRE11-inhibition assay, chromatin fractionation, loss-of-function (ZPET-depleted cells) with DNA resection and HR frequency readouts Genes & development High 30567999
2018 Cells lacking ZPET/ZNF280C display enhanced homologous recombination, accelerated replication forks under replication stress, and increased resistance to DSBs and PARP inhibition, establishing ZPET as a repressor of homologous recombination. Loss-of-function (ZPET-depleted cells) with HR frequency assay, replication fork speed measurement (DNA fiber assay), clonogenic survival after DSB-inducing agents and PARP inhibitor treatment Genes & development High 30567999
2022 ZNF280C occupies genomic loci marked by H3K27me3 as well as transcriptionally active regions, co-localizes with CTCF and cohesin, counteracts CTCF/cohesin activities to condense chromatin at tumor suppressor gene cis-elements, and recruits the epigenetic repressor SMCHD1 to maintain both focal and broad H3K27me3 levels. ChIP-seq (ZNF280C, H3K27me3, CTCF, cohesin), ATAC-seq, ZNF280C silencing (RNAi/CRISPRi) with H3K27me3 level quantification, co-immunoprecipitation (ZNF280C–SMCHD1 interaction), xenograft and in vivo colorectal tumorigenesis models Proceedings of the National Academy of Sciences of the United States of America High 35605119
2026 ZNF280C physically interacts with KMT5C (the H4K20me3 methyltransferase) and localizes specifically at H3K9me3-negative/H4K20me3-positive genomic sites, identifying ZNF280C as a novel binding partner that may recruit KMT5C to non-canonical, non-heterochromatic loci independently of HP1. Biochemical co-immunoprecipitation/pulldown (ZNF280C–KMT5C interaction), ChIP-seq co-localization analysis (ZNF280C at H3K9me3-/H4K20me3+ sites) bioRxivpreprint Medium 42182233

Source papers

Stage 0 corpus · 6 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2022 Can Exercise Training Alter Human Skeletal Muscle DNA Methylation? Metabolites 20 35323665
2018 Localized protein biotinylation at DNA damage sites identifies ZPET, a repressor of homologous recombination. Genes & development 17 30567999
2022 Zinc finger protein 280C contributes to colorectal tumorigenesis by maintaining epigenetic repression at H3K27me3-marked loci. Proceedings of the National Academy of Sciences of the United States of America 14 35605119
2024 Human transcriptome array analysis and diffusion tensor imaging in attention-deficit/hyperactivity disorder. Journal of psychiatric research 3 38412785
2026 KMT5C-H4K20me3 drives changes in epigenetic landscape independent of H3K9me3. bioRxiv : the preprint server for biology 0 42182233
2025 An investigation of a hemophilia A female with heterozygous intron 22 inversion and skewed X chromosome inactivation. Frontiers in genetics 0 39834547

Missed literature

Know a paper Affinage missed for ZNF280C? Flag it for the maintainers and the community.

No submissions yet.